Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
Moodys
Medtronic
US Army
McKesson
QuintilesIMS
Accenture

Generated: June 18, 2018

DrugPatentWatch Database Preview

ANTIZOL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Antizol, and what generic alternatives are available?

Antizol is a drug marketed by Par Pharm Inc and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in ANTIZOL is fomepizole. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fomepizole profile page.
Summary for ANTIZOL
Drug patent expirations by year for ANTIZOL
Pharmacology for ANTIZOL
Drug ClassAntidote
Synonyms for ANTIZOL
1H-Pyrazole, 4-methyl-
4-methyl pyrazole
4-methyl-1h_pyrazole
4-Methyl-1H-pyrazole
4-Methyl-1H-pyrazole, 97% 1g
4-METHYL-PYRAZOL
4-methyl-pyrazole
4-Methylpyrazol
4-Methylpyrazole
4-methylpyrazole monohydrochloride
4-methylpyrazole;Antizol;Antizol-Vet;Antizol
5-23-05-00031 (Beilstein Handbook Reference)
554M656
615557-09-0
7554-65-6
83LCM6L2BY
A9615
AB0018506
AB00390
AB00918526_06
AB00918526_07
AB2000244
AC-4833
AC1L1FV5
AC1Q2OK9
AC1Q2OKA
ACMC-209oys
ACN-004649
ACT05848
ACT08853
AJ-24276
AK-46480
AKOS000265586
ALBB-016317
AM20100737
AN-11585
Antizol (TN)
Antizol-vet
ANW-36626
BB 0257933
BBL015773
BC677698
BR-46480
BRN 0105204
C-5324
C07837
C4H6N2
CCG-204808
CHEBI:5141
CHEMBL1308
CJ-04506
CL3422
CTK2H7174
D00707
D02NJA
DB-022514
DB01213
DTXSID3040649
EINECS 231-445-0
EN300-50246
Fomepizol
Fomepizol [INN-Spanish]
fomepizole
Fomepizole (Antizol)
Fomepizole (JAN/USAN/INN)
Fomepizole (USAN/INN)
Fomepizole [USAN:INN:BAN]
Fomepizole [USAN:INN]
Fomepizole, 99%
Fomepizolum
Fomepizolum [INN-Latin]
FT-0626518
HE027354
homepizoru
HY-B0876
I11-0350
KB-308082
KB-39957
KS-000001GS
KSC377C7J
Lopac-M-1387
Lopac0_000723
LS-128524
LS20097
M0774
MCULE-2732751720
MFCD00005245
MLS001335923
MolPort-016-633-159
NCGC00015646-01
NCGC00015646-02
NCGC00015646-03
NCGC00015646-04
NCGC00162231-01
NSC-760365
NSC760365
Orphan brand of fomepizole
Paladin brand of fomepizole
Pharmakon1600-01506159
PubChem13055
PYRAZOLE, 4-METHYL-
Q-101886
RIKMMFOAQPJVMX-UHFFFAOYSA-N
RTR-037683
s137
S14-0570
s1717
SBB004402
SBI-0050701.P002
SC-04749
SMR000059088
ST2411524
ST45123338
STK256626
SY006499
TL8005172
TR-037683
TRA0026533
UNII-83LCM6L2BY
VP20110
Z969563038
ZB015137
ZINC897288
zlchem 884
ZLD0345

US Patents and Regulatory Information for ANTIZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc ANTIZOL fomepizole INJECTABLE;INJECTION 020696-001 Dec 4, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
UBS
Dow
AstraZeneca
Boehringer Ingelheim
Covington
Harvard Business School
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.